All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
D L Stenkamp, P M Iuvone, R Adle. Photomechanical movements of cultured embryonic photoreceptors: regulation by exogenous neuromodulators and by a regulable source of endogenous dopamine. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 14. issue 5 Pt 2. 1994-06-14. PMID:7910204. the effects of light on the cultured photoreceptors were inhibited by dopamine d2 receptor antagonists, and were attenuated by the dopaminergic neurotoxin 6-hydroxydopamine and by the dopamine synthesis inhibitor alpha-methyl-p-tyrosine. 1994-06-14 2023-08-12 chicken
C M Testa, D G Standaert, A B Young, J B Penne. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 14. issue 5 Pt 2. 1994-06-14. PMID:8182455. mglur1 was the only mglur message prominently expressed in the dopaminergic neurons of the substantia nigra pars compacta, suggesting the involvement of this receptor in the regulation of dopamine release from nigrostriatal terminals. 1994-06-14 2023-08-12 rat
J W van der Laan, L Eigeman, C J van 't Lan. Mesolimbic dopamine turnover effects of benzodiazepines do not correlate with sedative and muscle-relaxant potencies. Archives internationales de pharmacodynamie et de therapie. vol 326. 1994-06-10. PMID:8185409. benzodiazepines are known to decrease the dopamine turnover in the mesolimbic dopaminergic system in stimulated rather than in basal conditions. 1994-06-10 2023-08-12 Not clear
B Deleplanque, S Vitiello, M Le Moal, P J Neve. Modulation of immune reactivity by unilateral striatal and mesolimbic dopaminergic lesions. Neuroscience letters. vol 166. issue 2. 1994-06-09. PMID:8177502. asymmetrical modulation of immune reactivity by central dopaminergic pathways was suggested by previous reports which described an association between alterations of immune response and peculiar patterns of dopamine asymmetries in pathological and physiological situations. 1994-06-09 2023-08-12 mouse
N D Karanjia, A L Widdison, F J Lutrin, H A Rebe. Dopamine in models of alcoholic acute pancreatitis. Gut. vol 35. issue 4. 1994-06-07. PMID:8174995. using the model of acute haemorrhagic pancreatitis, it was previously shown that low dose dopamine (5 micrograms/kg.m) reduced the inflammatory score at 24 hours and that this effect was mediated by a reduction in pancreatic microvascular permeability acting via dopaminergic and beta adrenergic receptors. 1994-06-07 2023-08-12 Not clear
B H Westerink, P de Boer, M Santiago, J B De Vrie. Do nerve terminals and cell bodies of nigrostriatal dopaminergic neurons of the rat contain similar receptors? Neuroscience letters. vol 167. issue 1-2. 1994-06-06. PMID:8177506. the question was investigated whether dopamine release-controlling receptors are evenly distributed over somatodendritic sites and nerve terminals of nigrostriatal dopaminergic neurons of the rat. 1994-06-06 2023-08-12 rat
I Terleckyj, P K Sonsall. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors. The Journal of pharmacology and experimental therapeutics. vol 269. issue 1. 1994-06-02. PMID:7513362. the sigma receptor ligand (+/-)-bmy 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors. 1994-06-02 2023-08-12 mouse
M A Klitenick, P W Kaliva. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus. The Journal of pharmacology and experimental therapeutics. vol 269. issue 1. 1994-06-02. PMID:8169850. in contrast, the motor response by damgo in the md only partly involves dopaminergic mechanisms, perhaps via a presynaptic action because the effect was not altered by inhibiting impulse flow in mesoaccumbens dopamine neurons with baclofen. 1994-06-02 2023-08-12 Not clear
A de Bartolomeis, M C Austin, G A Goodwin, L P Spear, D Pickar, J N Crawle. Dopaminergic and peptidergic mRNA levels in juvenile rat brain after prenatal cocaine treatment. Brain research. Molecular brain research. vol 21. issue 3-4. 1994-06-01. PMID:7909578. levels of mrna for the dopamine transporter, tyrosine hydroxylase, cholecystokinin, d1 and d2 dopamine receptors and enkephalin were quantitated in relevant dopaminergic regions of forebrain and midbrain of offspring that were sacrificed on postnatal day 21. 1994-06-01 2023-08-12 rat
S Brené, M Herrera-Marschitz, H Persson, N Lindefor. Expression of mRNAs encoding dopamine receptors in striatal regions is differentially regulated by midbrain and hippocampal neurons. Brain research. Molecular brain research. vol 21. issue 3-4. 1994-06-01. PMID:8170351. the glutamate analogue kainic acid was injected into the hippocampus of intact or 6-hydroxydopamine deafferented rats to investigate the influence of hippocampal neurons on the expression of dopamine d1 and d2 receptor mrnas in subregions of the striatal complex and possible modulation by dopaminergic neurons. 1994-06-01 2023-08-12 rat
P M Groves, J C Linder, S J Youn. 5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum. Neuroscience. vol 58. issue 3. 1994-06-01. PMID:8170539. in contrast, recent studies using tyrosine hydroxylase or dopamine antibody techniques indicate that presumed dopaminergic axons form small symmetric contacts. 1994-06-01 2023-08-12 rat
J M Witki. Pharmacotherapy of cocaine abuse: preclinical development. Neuroscience and biobehavioral reviews. vol 18. issue 1. 1994-06-01. PMID:8170620. these compounds include buprenorphine, bromocriptine, desmethylimipramine, carbamazepine, dopaminergic agonists, antagonists and partial agonists, dopamine reuptake inhibitors, sigma ligands, serotonin antagonists, and excitatory amino acid antagonists. 1994-06-01 2023-08-12 Not clear
Y H Sohn, L V Metman, D Bravi, I Linfante, A Aotsuka, M M Mouradian, T N Chas. Levodopa peak response time reflects severity of dopamine neuron loss in Parkinson's disease. Neurology. vol 44. issue 4. 1994-05-24. PMID:8164839. peak response time to levodopa appears to reflect predominantly the status of compensatory presynaptic dopaminergic mechanisms and thus may provide an index to the degree of dopamine neuron degeneration in parkinsonian patients. 1994-05-24 2023-08-12 Not clear
R J Mandel, S L Hartgraves, J A Severson, J J Woodward, R E Wilcox, P K Randal. A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion-induced agonist sensitivity in the rat. Behavioural brain research. vol 59. issue 1-2. 1994-05-19. PMID:8155293. a quantitative estimate of the role of striatal d-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-ohda lesion-induced agonist sensitivity in the rat. 1994-05-19 2023-08-12 rat
G Martin, P Forte, A Luchsinger, F Mendoza, A Urbina-Quintana, O Hernandez Pieretti, E Romero, M Velasc. Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients. European journal of clinical pharmacology. vol 45. issue 6. 1994-05-19. PMID:8157035. we conclude that the pharmacological actions of intravenous dopamine on the cardiovascular system and on insulin secretion may be mediated by dopaminergic receptor stimulation. 1994-05-19 2023-08-12 Not clear
K Krajnak, J Manzanares, K J Lookingland, A A Nune. Gender differences in tuberoinfundibular dopaminergic neuronal activity in a photoperiodic rodent (Mesocricetus auratus). Brain research. vol 634. issue 1. 1994-05-18. PMID:8156387. this gender difference may be related to the higher levels of prolactin seen in females, but it is not associated with sex differences in median eminence dopamine or in the number of arcuate dopaminergic neurons. 1994-05-18 2023-08-12 Not clear
P J Karstaedt, H Kerasidis, J H Pincus, R Meloni, J Graham, K Gal. Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats. Experimental neurology. vol 126. issue 1. 1994-05-16. PMID:7512513. in order to evaluate the influence of dopaminergic transmission on regional brain utilization of serotonin (5ht), the effects of the destruction of the ascending dopamine (da) pathways on regional brain 5ht metabolism in the rat were examined. 1994-05-16 2023-08-12 rat
G H Tjon, T J De Vries, E Ronken, F Hogenboom, G Wardeh, A H Mulder, A N Schoffelmee. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation. European journal of pharmacology. vol 252. issue 2. 1994-05-13. PMID:7908881. interestingly, whereas [3h]dopamine release remained significantly reduced for at least 3 weeks following morphine withdrawal in chronically treated (tolerant/dependent) rats, neurotransmitter release from dopaminergic nerve terminals gradually increased above control values following cessation of repeated morphine administration. 1994-05-13 2023-08-12 rat
P A Tresco, S R Winn, S Tan, C B Jaeger, L A Greene, P Aebische. Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behavior. Cell transplantation. vol 1. issue 2-3. 1994-05-12. PMID:1344297. intrastriatal implantation of a dopaminergic cell line surrounded by a permeable, thermoplastic membrane was investigated as a method of long-term dopamine (da) delivery within the central nervous system (cns). 1994-05-12 2023-08-11 rat
N Waters, L Hansson, L Löfberg, A Carlsso. Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo. European journal of pharmacology. vol 251. issue 2-3. 1994-05-12. PMID:8149975. (+)-aj76 and (+)-uh232 but not raclopride seem to interact primarily with dopamine receptors in the terminal regions of the a9 and a10 dopaminergic fibers to exert their maximal effect on dopamine release in vivo. 1994-05-12 2023-08-12 Not clear